← All trials
NCT04487756
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2020
- Primary completion
- Oct 31, 2021
- Completion date
- Oct 31, 2023
- First posted
- Jul 27, 2020
- Last posted
- Sep 4, 2020
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Institute of Oncology Dr. Rosell (IOR)Lead sponsor
- RocheCollaborator
- University of BarcelonaCollaborator
- University Hospital Quirón Dexeus, BarcelonaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.